We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.30 | -4.62% | 68.10 | 66.20 | 69.80 | 72.00 | 70.00 | 72.00 | 102,787 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 22.49M | -25.73M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2021 13:13 | andymunchkin - Get a Nova Covid 19 test for the sake of your health before it's too late. You may have a re-occurring repetitive long Covid syndrome. | fuji99 | |
02/3/2021 13:11 | Getting stronger and stronger. Sorry shorters it's genuine holders time for us to smile. Suggest shorters close their positions before the imminent RNS or risk being cleaned out Great afternoon ahead.🔵 | smraynot | |
02/3/2021 13:07 | ReDZone BettsR us | andymunchkin | |
02/3/2021 13:05 | 600p ferAstarter | andymunchkin | |
02/3/2021 13:02 | Looking stronger now, basing nicely, if we can close above 742p we could really bounce. dyor active | srpactive | |
02/3/2021 12:55 | Stronger today, but still a lot of selling, which bedazzles me, given the latest newsflow... | picardy | |
02/3/2021 12:53 | SummerIs Cummings scamedemic cummings toEnds | andymunchkin | |
02/3/2021 12:08 | Novacyt's ! | pastiche21 | |
02/3/2021 12:07 | A good description of novocyte assays for identifying variants (2 February):https://ww | pastiche21 | |
02/3/2021 12:02 | It’s not sequencing, fuji, it’s identifying a short sequence. Hope that’s clear. To monitor the spread of the variants and identify the individuals we are on the money. | freedosh | |
02/3/2021 10:43 | Sequencing requirements: - - - | fuji99 | |
02/3/2021 09:57 | Thanks for passing on your understanding freedosh. | bobdown2 | |
02/3/2021 09:48 | Gaining blue by the hour. Could finish at £8+ without RNS. With RNS 🚀🚀 | smraynot | |
02/3/2021 09:47 | For clarification. A couple of peeps (minority) are confusing our SNP tests with sequencing. At the mo I think positive LFTs are being sent for sequencing. Our Variplex (are we due an official launch RNS?) will bypass this as the kit will test three main variants and two others of potential interest. This is not sequencing (if you like effectively sequences a tiny run of a length of the individual unique variant). In effect it bypasses the need to do full and very costly sequencing in the vast majority. Occasional sequencing will be done in a small minority to monitor emergence of new variants over the entire COVID genome. Variplex will be an absolute winner as the variants progressively dominate. I assume major diagnostics companies will be working towards the same but, to me, we again appear to be first movers. | freedosh | |
02/3/2021 09:15 | It would be nice to see figures on qpcr sales. An update with qpcr16 and 32 sales would circumvent non disclosure agreements and would give shareholders more information on their investment. Mind you the new product releases rns was outstanding. And is the yardstick that most companies will be judged on this year. | bobdown2 | |
02/3/2021 09:01 | When it's put like that and given the vast expansions going on in other testing companies as well as multi million pound investments, like biograd lab recently funded by the people of Liverpool ....you'd think that the first mover and heavyweight Novacyt have been quietly scratching the right backs | mcrudden | |
02/3/2021 08:52 | Why would anyone sell. Option 1 Mega profits and dividend Option 2 Aggressive expansion self funded and FTSE250. Option 3 Large Pharma bid for NCYT at £25+ RNS to follow. | smraynot | |
02/3/2021 08:42 | No comment lolNot selling a single share here anytime soon that's for sure | mcrudden | |
02/3/2021 08:42 | TTTT= Terrific Tuesday Tests Tenpounds. What more can you ask. RNS to follow. | smraynot | |
02/3/2021 08:41 | We can split hairs about many things but looking at the graphs on the .GOV website I would say that the graphs for hospitalizations, cases and deaths for Covid-19 graphs are a "sell" with numbers firmly trending down. Hurrah! (And so say all of us). Meanwhile, the "Testing" graph remains a buy with the medium-term trends for testing remaining firmly up. Hurrah (we are set to be lucky beneficiaries) Vigilance will mean testing continues at an elevated level for the foreseeable. | undervaluedassets | |
02/3/2021 08:37 | In the video on NCYT, GSK and AZN are present. Joint-Venture on Diagnostics & Testing on the cards ? | fuji99 | |
02/3/2021 08:36 | f I am just looking at the now, if we can close above 742p, we might recover quicker. dyor | srpactive | |
02/3/2021 08:31 | How many takeover bids will happen throughout this pandemic ? Renishaw [RSW] just being sold by the management ... When NCYT is befriended by the big fish, what can one anticipate for the near future ? | fuji99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions